Completed PHASE3 INTERVENTIONAL 2-arm NCT00784134

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR III)

Sponsor: Emissary International LLC

Updated 9 times since 2017 Last updated: Nov 9, 2018 Started: Jul 31, 2009 Primary completion: Jul 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Intraventricular Hemorrhage and is currently completed. Emissary International LLC leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2019 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jun 2018 — Jan 2019 [monthly]

Completed PHASE3
Aug 2017 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Aug 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emissary International LLC
Genentech, Inc.
Johns Hopkins University
National Institute of Neurological Disorders and Stroke (NINDS)

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abington, United States , Baltimore, United States , Barcelona, Spain , Bern, Switzerland , Birmingham, United States , Budapest, Hungary , Buffalo, United States , Camden, United States , Charleston, United States , Chicago, United States and 57 more locations